0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Children Influenza Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19X13292
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Children Influenza Vaccine Market Research Report 2023
BUY CHAPTERS

Global Children Influenza Vaccine Market Research Report 2025

Code: QYRE-Auto-19X13292
Report
July 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Children Influenza Vaccine Market Size

The global market for Children Influenza Vaccine was valued at US$ 1720 million in the year 2024 and is projected to reach a revised size of US$ 2240 million by 2031, growing at a CAGR of 3.9% during the forecast period.

Children Influenza Vaccine Market

Children Influenza Vaccine Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Children Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children Influenza Vaccine.
The Children Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Children Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Children Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Children Influenza Vaccine Market Report

Report Metric Details
Report Name Children Influenza Vaccine Market
Accounted market size in year US$ 1720 million
Forecasted market size in 2031 US$ 2240 million
CAGR 3.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Nasal Spray
  • Injection
Segment by Application
  • Public
  • Private
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, CSL, GSK, Viatris, Hulan Bio, AstraZeneca, CCBIO, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Children Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Children Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Children Influenza Vaccine Market growing?

Ans: The Children Influenza Vaccine Market witnessing a CAGR of 3.9% during the forecast period 2025-2031.

What is the Children Influenza Vaccine Market size in 2031?

Ans: The Children Influenza Vaccine Market size in 2031 will be US$ 2240 million.

Who are the main players in the Children Influenza Vaccine Market report?

Ans: The main players in the Children Influenza Vaccine Market are Sanofi, CSL, GSK, Viatris, Hulan Bio, AstraZeneca, CCBIO, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Children Influenza Vaccine Market report?

Ans: The Applications covered in the Children Influenza Vaccine Market report are Public, Private

What are the Type segmentation covered in the Children Influenza Vaccine Market report?

Ans: The Types covered in the Children Influenza Vaccine Market report are Nasal Spray, Injection

Recommended Reports

Pediatric & Child Vaccines

Influenza Related Markets

Vaccine Logistics & Storage

1 Children Influenza Vaccine Market Overview
1.1 Product Definition
1.2 Children Influenza Vaccine by Type
1.2.1 Global Children Influenza Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Nasal Spray
1.2.3 Injection
1.3 Children Influenza Vaccine by Application
1.3.1 Global Children Influenza Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Global Children Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Children Influenza Vaccine Revenue 2020-2031
1.4.2 Global Children Influenza Vaccine Sales 2020-2031
1.4.3 Global Children Influenza Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Children Influenza Vaccine Market Competition by Manufacturers
2.1 Global Children Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Children Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Children Influenza Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Children Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Children Influenza Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Children Influenza Vaccine, Date of Enter into This Industry
2.8 Global Children Influenza Vaccine Market Competitive Situation and Trends
2.8.1 Global Children Influenza Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Children Influenza Vaccine Players Market Share by Revenue
2.8.3 Global Children Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Children Influenza Vaccine Market Scenario by Region
3.1 Global Children Influenza Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Children Influenza Vaccine Sales by Region: 2020-2031
3.2.1 Global Children Influenza Vaccine Sales by Region: 2020-2025
3.2.2 Global Children Influenza Vaccine Sales by Region: 2026-2031
3.3 Global Children Influenza Vaccine Revenue by Region: 2020-2031
3.3.1 Global Children Influenza Vaccine Revenue by Region: 2020-2025
3.3.2 Global Children Influenza Vaccine Revenue by Region: 2026-2031
3.4 North America Children Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Children Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Children Influenza Vaccine Sales by Country (2020-2031)
3.4.3 North America Children Influenza Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Children Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Children Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Children Influenza Vaccine Sales by Country (2020-2031)
3.5.3 Europe Children Influenza Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Children Influenza Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Children Influenza Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Children Influenza Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Children Influenza Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Children Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Children Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Children Influenza Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Children Influenza Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Children Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Children Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Children Influenza Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Children Influenza Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Children Influenza Vaccine Sales by Type (2020-2031)
4.1.1 Global Children Influenza Vaccine Sales by Type (2020-2025)
4.1.2 Global Children Influenza Vaccine Sales by Type (2026-2031)
4.1.3 Global Children Influenza Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Children Influenza Vaccine Revenue by Type (2020-2031)
4.2.1 Global Children Influenza Vaccine Revenue by Type (2020-2025)
4.2.2 Global Children Influenza Vaccine Revenue by Type (2026-2031)
4.2.3 Global Children Influenza Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Children Influenza Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Children Influenza Vaccine Sales by Application (2020-2031)
5.1.1 Global Children Influenza Vaccine Sales by Application (2020-2025)
5.1.2 Global Children Influenza Vaccine Sales by Application (2026-2031)
5.1.3 Global Children Influenza Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Children Influenza Vaccine Revenue by Application (2020-2031)
5.2.1 Global Children Influenza Vaccine Revenue by Application (2020-2025)
5.2.2 Global Children Influenza Vaccine Revenue by Application (2026-2031)
5.2.3 Global Children Influenza Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Children Influenza Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Children Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Children Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Children Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Children Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Hulan Bio
6.5.1 Hulan Bio Company Information
6.5.2 Hulan Bio Description and Business Overview
6.5.3 Hulan Bio Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hulan Bio Children Influenza Vaccine Product Portfolio
6.5.5 Hulan Bio Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Children Influenza Vaccine Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 CCBIO
6.7.1 CCBIO Company Information
6.7.2 CCBIO Description and Business Overview
6.7.3 CCBIO Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CCBIO Children Influenza Vaccine Product Portfolio
6.7.5 CCBIO Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Children Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Company Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BCHT Children Influenza Vaccine Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Company Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu GDK Children Influenza Vaccine Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Company Information
6.11.2 KM Biologics Description and Business Overview
6.11.3 KM Biologics Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 KM Biologics Children Influenza Vaccine Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Children Influenza Vaccine Industry Chain Analysis
7.2 Children Influenza Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Children Influenza Vaccine Production Mode & Process Analysis
7.4 Children Influenza Vaccine Sales and Marketing
7.4.1 Children Influenza Vaccine Sales Channels
7.4.2 Children Influenza Vaccine Distributors
7.5 Children Influenza Vaccine Customer Analysis
8 Children Influenza Vaccine Market Dynamics
8.1 Children Influenza Vaccine Industry Trends
8.2 Children Influenza Vaccine Market Drivers
8.3 Children Influenza Vaccine Market Challenges
8.4 Children Influenza Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Children Influenza Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Children Influenza Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Children Influenza Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Children Influenza Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Children Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Children Influenza Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Children Influenza Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Children Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Children Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Children Influenza Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Children Influenza Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Children Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Influenza Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Children Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Children Influenza Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Children Influenza Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Children Influenza Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Children Influenza Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Children Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Children Influenza Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Children Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Children Influenza Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Children Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Children Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Children Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Children Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Children Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Children Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Children Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Children Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Children Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Children Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Children Influenza Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Children Influenza Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Children Influenza Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Children Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Children Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Children Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Children Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Children Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Children Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Children Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Children Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Children Influenza Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Children Influenza Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Children Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Children Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Children Influenza Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Children Influenza Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Children Influenza Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Children Influenza Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Children Influenza Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Children Influenza Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Children Influenza Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Children Influenza Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Children Influenza Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Children Influenza Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Children Influenza Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Children Influenza Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Children Influenza Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Children Influenza Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Children Influenza Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Children Influenza Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Children Influenza Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Children Influenza Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Children Influenza Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Children Influenza Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Children Influenza Vaccine Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CSL Children Influenza Vaccine Product
 Table 79. CSL Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Children Influenza Vaccine Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Viatris Company Information
 Table 86. Viatris Description and Business Overview
 Table 87. Viatris Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Viatris Children Influenza Vaccine Product
 Table 89. Viatris Recent Developments/Updates
 Table 90. Hulan Bio Company Information
 Table 91. Hulan Bio Description and Business Overview
 Table 92. Hulan Bio Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Hulan Bio Children Influenza Vaccine Product
 Table 94. Hulan Bio Recent Developments/Updates
 Table 95. AstraZeneca Company Information
 Table 96. AstraZeneca Description and Business Overview
 Table 97. AstraZeneca Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AstraZeneca Children Influenza Vaccine Product
 Table 99. AstraZeneca Recent Developments/Updates
 Table 100. CCBIO Company Information
 Table 101. CCBIO Description and Business Overview
 Table 102. CCBIO Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CCBIO Children Influenza Vaccine Product
 Table 104. CCBIO Recent Developments/Updates
 Table 105. Sinovac Company Information
 Table 106. Sinovac Description and Business Overview
 Table 107. Sinovac Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sinovac Children Influenza Vaccine Product
 Table 109. Sinovac Recent Developments/Updates
 Table 110. BCHT Company Information
 Table 111. BCHT Description and Business Overview
 Table 112. BCHT Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. BCHT Children Influenza Vaccine Product
 Table 114. BCHT Recent Developments/Updates
 Table 115. Jiangsu GDK Company Information
 Table 116. Jiangsu GDK Description and Business Overview
 Table 117. Jiangsu GDK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Jiangsu GDK Children Influenza Vaccine Product
 Table 119. Jiangsu GDK Recent Developments/Updates
 Table 120. KM Biologics Company Information
 Table 121. KM Biologics Description and Business Overview
 Table 122. KM Biologics Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. KM Biologics Children Influenza Vaccine Product
 Table 124. KM Biologics Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Children Influenza Vaccine Distributors List
 Table 128. Children Influenza Vaccine Customers List
 Table 129. Children Influenza Vaccine Market Trends
 Table 130. Children Influenza Vaccine Market Drivers
 Table 131. Children Influenza Vaccine Market Challenges
 Table 132. Children Influenza Vaccine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Children Influenza Vaccine
 Figure 2. Global Children Influenza Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Children Influenza Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Nasal Spray Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Children Influenza Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Children Influenza Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Public
 Figure 9. Private
 Figure 10. Global Children Influenza Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Children Influenza Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Children Influenza Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Children Influenza Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Children Influenza Vaccine Report Years Considered
 Figure 15. Children Influenza Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Children Influenza Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Children Influenza Vaccine Players: Market Share by Revenue in Children Influenza Vaccine in 2024
 Figure 18. Children Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Children Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Children Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Children Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Children Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Children Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Children Influenza Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Children Influenza Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Children Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Children Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Children Influenza Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Children Influenza Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Children Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Children Influenza Vaccine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Children Influenza Vaccine by Type (2020-2031)
 Figure 54. Global Children Influenza Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Children Influenza Vaccine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Children Influenza Vaccine by Application (2020-2031)
 Figure 57. Global Children Influenza Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Children Influenza Vaccine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network